Skip to main content
Policy & Funding· Daily Pulse

School Access to Naloxone Act gets a bipartisan reintroduction — and a real path

Sens. Merkley (D-OR) and Scott (R-FL) revived S.3588 in January. With SAMHSA's harm-reduction posture narrowing, naloxone in schools is the rare opioid-policy lane with bipartisan air cover.

ByThe Rize NewsroomMay 21, 20262 min readOpioids

School Access to Naloxone Act gets a bipartisan reintroduction — and a real path

S.3588 — the School Access to Naloxone Act of 2026 — was reintroduced on <span class="stat">January 7, 2026</span> by Sens. Jeff Merkley (D-OR) and Rick Scott (R-FL), with referral to the Senate HELP Committee. The bill amends the Public Health Service Act to provide federal funding for training school personnel to administer drugs and devices for emergency treatment of suspected opioid overdose, and to ensure schools maintain accessible supply.

Why now

Two contextual signals matter here. First, the SAMHSA April 24 letter to grantees (covered in our May 3 feature) explicitly preserves naloxone funding while restricting nearly every other harm-reduction supply category. That makes school-based naloxone distribution one of the few federal-funding lanes still actively expanding rather than contracting. Second, the School-Based Health Alliance is endorsing, and the bipartisan sponsor structure — a progressive Oregon Democrat and a conservative Florida Republican — gives the bill the political cover that its 118th-Congress predecessor (S.2946) lacked.

What it does, plainly

The bill authorizes HHS, through SAMHSA, to issue grants to local educational agencies and state education agencies for: (1) the purchase of opioid overdose reversal drugs and devices, (2) the training of school personnel — including school nurses, counselors, athletic trainers, and willing teachers — to administer them, and (3) protocols for storing, signing out, and reporting use. It does not preempt state Good Samaritan laws or modify standing-order frameworks; those continue to be governed at the state level. For Arizona, this would layer on top of the existing AHCCCS-pharmacy standing order and the Hikma settlement-funded supply pipeline that begins arriving in <span class="stat">September 2026</span>.

What we’re watching

Whether the bill clears HELP Committee markup before the August recess is the operative milestone. If it does, the bipartisan structure makes floor passage more plausible than the 118th-Congress version. Track GovTrack and BillTrack50 for committee movement.

Find naloxone resources near you in Arizona

If you or someone you know is in crisis, SAMHSA’s National Helpline is available 24/7, free and confidential.

Filed Under

policyharm-reductionsocial-culturalNaloxone

Continue reading

More from this section